Skip to content 
The Comprehensive 2024 Gastroenterology Update
Overview
This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2024 program include:
- Updated guidelines for the use of biologics in IBD
- Therapeutic drug monitoring in IBD treatment
- Management of the older adult with IBD
- Updated guidelines for treatment of C. difficile infection
- Managing GI complications of immunotherapy
- Improved management of IBS
- Tips to managing fecal incontinence
- Management of refractory GERD
- Expanded genetic testing options to diagnose hereditary GI cancer syndromes
- Management of fatty liver disease in 2024
- How to diagnose and manage cirrhosis
- How to improve your adenoma detection rate (ADR)
- Steps to ensure delivery of high-quality colonoscopic care
- Techniques to effectively control acute GI bleeding
- Endoscopic management of obesity
- When FMT is indicated for treatment
- Impact of COVID on the GI tract
- New strategies to treat common GI problems
- A comprehensive update of national guidelines
As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover:
- IBD
- GI Complications of Immunotherapy
- Microscopic Colitis
- Fatty Liver
- Barrett’s Esophagus
- Eosinophilic Esophagitis
- C. difficile Colitis
- Alcohol-Related Liver Disease
- Autoimmune Hepatitis
- IBS
- Refractory GERD
- Acute Pancreatitis
- Chronic Pancreatitis
- Celiac Disease
- GI Bleeding
- High Risk for Colorectal Cancer
Recent Advances and Innovations
Clinicians can rely on this program for education on:
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- Managing refractory pouchitis
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
- The stool microbiome: understanding the science behind clinical applications
- Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
- Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
- Endoscopic approaches to managing obesity
This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.
Who Should Attend
- Gastroenterologists
- Internists
- Surgeons
- Nurse Practitioners
- Physician Assistants
Dr. Samantha Lee, Gastroenterologist –
"This was the most impactful gastroenterology conference I've attended in my 15-year career. The Harvard faculty did an outstanding job translating cutting-edge research into practical strategies I can immediately implement to improve patient outcomes. I left feeling energized and equipped with the latest evidence-based best practices."
Dr. Michael Chen, Inflammatory Bowel Disease Expert –
"As a seasoned IBD specialist, I was blown away by the breadth and depth of the content covered at the Harvard Gastroenterology Review. The sessions on novel biologic therapies and personalized treatment algorithms were absolute game-changers. I highly recommend this program to any gastroenterologist seeking to elevate their clinical skills."
Dr. Fatima Sharma, Gastroenterology Hospitalist –
"This comprehensive review course exceeded all of my expectations. Not only did it provide essential updates across the full spectrum of gastroenterology, but it also featured cutting-edge research on the gut microbiome and its implications for patient care ."
Dr. David Nguyen, Gastroenterology Fellow –
"The Harvard Gastroenterology Review is a must-attend event for any GI clinician. The faculty presentations were engaging, the content was clinically relevant, and the networking opportunities were invaluable. I'm already looking forward to next year's program."
Dr. David Nguyen, Gastroenterology Fellow –
"The Harvard Gastroenterology Review is a must-attend event for any GI clinician. The faculty presentations were engaging, the content was clinically relevant, and the networking opportunities were invaluable. I'm already looking forward to next year's program."
Dr. Sarah Patel, Family Medicine Physician –
"As a primary care physician, I found the Harvard Gastroenterology Review to be an immensely valuable investment of my time. The sessions on GI diagnostics, treatment guidelines, and interprofessional collaboration have already transformed the way I approach GI health in my practice."
Dr. Amelia Flores, Chief of Gastroenterology –
"This conference single-handedly reignited my passion for gastroenterology. The innovative research, cutting-edge therapies, and emphasis on holistic patient care have inspired me to think more creatively about GI disease management. Bravo to the Harvard team for organizing such an exceptional event!"